Optimisation Strategy for Emergency Tracheal Intubation
NCT ID: NCT05539391
Last Updated: 2025-09-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
1500 participants
INTERVENTIONAL
2023-01-14
2026-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Tracheal Intubation and Prehospital Emergency Setting
NCT03486171
Bougies as Aid for Endotracheal Intubation Via Video Laryngoscopy During Continuous Chest Compressions
NCT05689125
Awake Endotracheal Intubation in Cervical Injury
NCT05619965
Clinical Outcome of Endotracheal Intubation in Non-trauma Patients
NCT05795231
Fibre-optic Guided Tracheal Intubation Through SADs
NCT03118596
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Treatment group
Combination rapid sequence intubation (RSI) with use of rocuronium and the bag-mask ventilation between induction and Gum Elastic Bougie GEB will be systematically used at the first attempt to facilitate intubation.
Data patient
Medical History and characteristic of patient
Physical examination
Arterial pressure, arterial oxygen saturation, heart rate
Rapid sequence intubation (RSI) : Rocuronium /Bag-mask ventilation /GEB
Rapid sequence intubation (RSI) will be performed with use of rocuronium as paralytic agent (1.2 mg/ kg). Bag-mask ventilation between induction and laryngoscopy will be performed. The GEB will be systematically used at the first attempt to facilitate intubation.
Control Group
Physicians will be reminded of the current recommendations for emergency intubation: Rapid sequence intubation (RSI) using succinylcholine and use of GEB to facilitate intubation in case of intubation failure under direct laryngoscopy.
Data patient
Medical History and characteristic of patient
Physical examination
Arterial pressure, arterial oxygen saturation, heart rate
Rapid sequence intubation (RSI) : Recommendations for emergency intubation
Rapid sequence intubation (RSI) using succinylcholine as a paralytic agent (1 mg/kg), no systematic bag-mask ventilation between induction and laryngoscopy, use of GEB to facilitate intubation in case of intubation failure under direct laryngoscopy.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Data patient
Medical History and characteristic of patient
Physical examination
Arterial pressure, arterial oxygen saturation, heart rate
Rapid sequence intubation (RSI) : Rocuronium /Bag-mask ventilation /GEB
Rapid sequence intubation (RSI) will be performed with use of rocuronium as paralytic agent (1.2 mg/ kg). Bag-mask ventilation between induction and laryngoscopy will be performed. The GEB will be systematically used at the first attempt to facilitate intubation.
Rapid sequence intubation (RSI) : Recommendations for emergency intubation
Rapid sequence intubation (RSI) using succinylcholine as a paralytic agent (1 mg/kg), no systematic bag-mask ventilation between induction and laryngoscopy, use of GEB to facilitate intubation in case of intubation failure under direct laryngoscopy.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient with all conditions (trauma, dyspnea, coma, overdoses, and shock) except those in cardiac arrest will be included.
Exclusion Criteria
* Patient who have contraindication to bag face mask ventilation before intubation (ongoing emesis, hematemesis, or hemoptysis).
* Patient that are not members of a medical aid scheme (beneficiary or main member).
* Patient under specific protection measures: pregnant, parturient or nursing women; legal protection or deprived of liberty: patient under judicial protection, patient under guardianship/curatorship.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Bordeaux
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Xavier COMBES, Pr
Role: PRINCIPAL_INVESTIGATOR
Université Hospital, Bordeaux
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU d'Angers
Angers, , France
CH Carnelle Portes de l'Oise
Beaumont-sur-Oise, , France
AP-HP - Hôpital Avicenne
Bobigny, , France
CHU de Bordeaux - Hôpital Pellegrin
Bordeaux, , France
CH de Pontoise René Dubos
Cergy-Pontoise, , France
AP-HP - Hôpital Henri Mondor
Créteil, , France
CHU de Dijon
Dijon, , France
GH Eaubonne Montmorency Hôpital Simone VEIL
Eaubonne, , France
AP-HP - Hôpital Raymond Poincaré
Garches, , France
CHU de Grenoble - Hôpital Nord La Tronche
La Tronche, , France
CH de Versailles - Site André Mignot
Le Chesnay, , France
HCL - Hôpital Edouard Herriot
Lyon, , France
GH Sud Ile de France
Melun, , France
CHU de Montpellier Site Lapeyronie
Montpellier, , France
CHU de Nantes - Hôpital Hôtel Dieu
Nantes, , France
AP-HP - Hôpital Lariboisière
Paris, , France
AP-HP - Hôpital Pitié-Salpétrière
Paris, , France
AP-HP - Hôpital Necker
Paris, , France
CHU Poitiers - Hôpital la Milétrie
Poitiers, , France
CHU de la Réunion - site Sud
Saint-Pierre, , France
GH Sélestat Obernai
Sélestat, , France
CHU Toulouse - Hôpital Purpan
Toulouse, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CHUBX 2021/25
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.